Status: Recruiting
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.
Participants needed: 480
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Quercis Pharma AGUpdated: Feb 2, 2026Locations: 3
Eligibility criteria
Participants must have histological or cytological confirmed pancreatic adenocar... [+11]
Participants with known brain metastases [+11]